Failure of IGF-1R inhibition results from two compensatory mechanisms: (1) IGF-2 is increased during treatment with IGF-1R mAb (52) which signals through IR-A, which is known to promote cancer survival (53). This evidence concerns the gene IGF1R and cancer.